Editorial
Glypican-1 in exosomes as biomarker for early detection of pancreatic cancer
Annals of Translational Medicine
2016;
4
(4)
:64
.
(29 February 2016)
Visnagin—a new protectant against doxorubicin cardiotoxicity? Inhibition of mitochondrial malate dehydrogenase 2 (MDH2) and beyond
Annals of Translational Medicine
2016;
4
(4)
:65
.
(29 February 2016)
Significance of IASLC/ATS/ERS classification for early-stage lung adenocarcinoma patients in predicting benefit from adjuvant chemotherapy
Annals of Translational Medicine
2016;
4
(4)
:66
.
(29 February 2016)
Getting familiar with the forthcoming eighth edition of TNM classification of lung cancer: from the T to N and M descriptors
Annals of Translational Medicine
2016;
4
(4)
:67
.
(29 February 2016)
Intraoperative brain cancer detection with Raman spectroscopy in humans
Annals of Translational Medicine
2016;
4
(4)
:68
.
(29 February 2016)
Original Article
In silico analysis of polymorphisms in microRNAs that target genes affecting aerobic glycolysis
Annals of Translational Medicine
2016;
4
(4)
:69
.
(29 February 2016)
Comparison of bone marrow sparing intensity modulated radiotherapy (IMRT) and three-dimensional conformal radiotherapy (3DCRT) in carcinoma of anal canal: a prospective study
Annals of Translational Medicine
2016;
4
(4)
:70
.
(29 February 2016)
Comparative study of tumor markers in patients with colorectal carcinoma before and after chemotherapy
Annals of Translational Medicine
2016;
4
(4)
:71
.
(29 February 2016)
Mental health issues amongst medical students in Asia: a systematic review [2000–2015]
Annals of Translational Medicine
2016;
4
(4)
:72
.
(29 February 2016)
Diagnosis, disease stage, and distress of Chinese cancer patients
Annals of Translational Medicine
2016;
4
(4)
:73
.
(29 February 2016)
Toxicity and early outcomes of regorafenib in multiply pre-treated metastatic colorectal adenocarcinoma-experience from a tertiary cancer centre in India
Annals of Translational Medicine
2016;
4
(4)
:74
.
(29 February 2016)
Review Article
Determining the frequency of sporadic cases of rare X-linked disorders
Annals of Translational Medicine
2016;
4
(4)
:75
.
(29 February 2016)
New horizons of non-emergent use of extracorporeal membranous oxygenator support
Annals of Translational Medicine
2016;
4
(4)
:76
.
(29 February 2016)
Rethinking autonomy: decision making between patient and surgeon in advanced illnesses
Annals of Translational Medicine
2016;
4
(4)
:77
.
(29 February 2016)
Big-data Clinical Trial Column1
Reshaping and aggregating data: an introduction to reshape package
Annals of Translational Medicine
2016;
4
(4)
:78
.
(29 February 2016)
Perspective
How to improve assessment of balance in baseline characteristics of clinical trial participants—example from PROSEVA trial data
Annals of Translational Medicine
2016;
4
(4)
:79
.
(29 February 2016)
Targeting epidermal growth factor receptor for head and neck squamous cell carcinoma: still lost in translation?
Annals of Translational Medicine
2016;
4
(4)
:80
.
(29 February 2016)
Commentary
Forget skin scrubbing and other antiseptics: prevent catheter related infections using chlorhexidine plus alcohol
Annals of Translational Medicine
2016;
4
(4)
:81
.
(29 February 2016)
Fractionated radiotherapy combined with PD-1 pathway blockade promotes CD8 T cell-mediated tumor clearance for the treatment of advanced malignancies
Annals of Translational Medicine
2016;
4
(4)
:82
.
(29 February 2016)
The evolving role of renal mass biopsy
Annals of Translational Medicine
2016;
4
(4)
:83
.
(29 February 2016)
Case Report
Postmenopausal vaginal bleeding as initial presentation of gastric cancer: a case report with literature review of prognostic factors and treatment of krukenberg tumor
Annals of Translational Medicine
2016;
4
(4)
:84
.
(29 February 2016)
Letter to the Editor
STARD 2015: updated reporting guidelines for all diagnostic accuracy studies
Annals of Translational Medicine
2016;
4
(4)
:85
.
(29 February 2016)
Disclosure:
1. The series “Big-data Clinical Trial Column” was commissioned by the editorial office, Annals of Translational Medicine without any sponsorship or funding.